ArticleEndocrine journal2026

Lenvatinib in radioiodine-refractory differentiated thyroid cancer: a real-world institutional analysis.

Sueyoshi Moritani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.